4.3 Article

Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Clinical applications of the CellSearch platform in cancer patients

Sabine Riethdorf et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Article Oncology

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis

Maryou B. Lambros et al.

CLINICAL CANCER RESEARCH (2018)

Review Oncology

Liquid Biopsy: Current Status and Future Perspectives

Sonja Mader et al.

ONCOLOGY RESEARCH AND TREATMENT (2017)

Review Pathology

Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution

Nikolas H. Stoecklein et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Review Pathology

Improving the CellSearch® system

J. F. Swennenhuis et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)

Review Oncology

Circulating tumor cells in breast cancer

Francois-Clement Bidard et al.

MOLECULAR ONCOLOGY (2016)

Review Hematology

Adverse events in apheresis: An update of the WAA registry data

M. Mortzell Henriksson et al.

TRANSFUSION AND APHERESIS SCIENCE (2016)

Review Oncology

Ex Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy

Shyamala Maheswaran et al.

CANCER RESEARCH (2015)

Article Multidisciplinary Sciences

Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

Johannes C. Fischer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Oncology

Challenges in the Enumeration and Phenotyping of CTC

Frank A. W. Coumans et al.

CLINICAL CANCER RESEARCH (2012)

Article Biochemical Research Methods

Statistical considerations for enumeration of circulating tumor cells

Arjan G. J. Tibbe et al.

CYTOMETRY PART A (2007)